Publications by authors named "Simu Thomas"

Claim this Profile
H
HTA Evidence in Rare Diseases: Just Rare or Also Special?
Anirban Basu, Simu K Thomas, Richard H Chapman, Jason Spangler

Pharmacoeconomics· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Utility Analysis of Ravulizumab Compared with Eculizumab in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria.
Thomas O'Connell, Marric Buessing, Scott Johnson, Lufei Tu, Simu K Thomas

Pharmacoeconomics· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost associated with hematopoietic stem cell transplantation: a retrospective claims data analysis in Germany.
Lukas Mayerhoff, Moritz Lehne, Lennart Hickstein, Tayyab Salimullah, Sigurd Prieur, Simu K Thomas

J Comp Eff Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden following allogeneic hematopoietic stem cell transplant in patients with diffuse large B-cell lymphoma.
Richard T Maziarz, Yanni Hao, Annie Guerin, Genevieve Gauthier, Marjolaine Gauthier-Loiselle, Simu K Thomas

Leuk Lymphoma· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Five-year direct costs of acute lymphoblastic leukemia pediatric patients undergoing allogeneic stem cell transplant.
Richard T Maziarz, Annie Guérin, Geneviève Gauthier, Julie Heroux, Maryia Zhdanava, Simu K Thomas

Int J Hematol Oncol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Patient-Reported Outcome Measures in the Assessment of Central Nervous System Agents.
Ari Gnanasakthy, Carla DeMuro, Marci Clark, Margaret Mordin, Simu Thomas

Ther Innov Regul Sci· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial.
Paul Mitchell, Lieven Annemans, Meghan Gallagher, Rafiq Hasan, Simu Thomas

Br J Ophthalmol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models.
Balázs Nagy, Alan Brennan, Agnes Brandtmüller, Simu K Thomas, Sean D Sullivan

Int J Geriatr Psychiatry· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of treatments for wet age-related macular degeneration.
Paul Mitchell, Lieven Annemans, Richard White, Meghan Gallagher, Simu Thomas

Pharmacoeconomics· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association between adherence to levodopa/carbidopa/entacapone therapy and healthcare utilization and costs among patients with Parkinson's disease: a retrospective claims-based analysis.
Thomas E Delea, Simu K Thomas, May Hagiwara

CNS Drugs· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence with levodopa/carbidopa/entacapone versus levodopa/carbidopa and entacapone as separate tablets in patients with Parkinson's disease.
Thomas E Delea, Simu K Thomas, May Hagiwara, L Mancione

Curr Med Res Opin· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting time to nursing home placement based on activities of daily living scores--a modelling analysis using data on Alzheimer's disease patients receiving rivastigmine or donepezil.
Hind T Hatoum, Simu K Thomas, Swu-Jane Lin, Roger Lane, Roger Bullock

J Med Econ· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alzheimer's disease treatment: assessing caregiver preferences for mode of treatment delivery.
Linda Abetz, Diana Rofail, Polyxane Mertzanis, Rebecca Heelis, Kathleen Rosa, Simu Thomas

Adv Ther· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
Thomas E Delea, May Hagiwara, Simu K Thomas, Jean-Francois Baladi, Pradyumna D Phatak, Thomas D Coates

Am J Hematol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review.
Thomas E Delea, John Edelsberg, Oleg Sofrygin, Simu K Thomas, Jean-Francois Baladi, Thomas D Coates

Transfusion· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment interruptions and non-adherence with imatinib and associated healthcare costs: a retrospective analysis among managed care patients with chronic myelogenous leukaemia.
Theodore Darkow, Henry J Henk, Simu K Thomas, Weiwei Feng, Jean-Francois Baladi

Pharmacoeconomics· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspective.
Thomas E Delea, Oleg Sofrygin, Simu K Thomas, Jean-Francois Baladi, Pradyumna D Phatak, Thomas D Coates

Pharmacoeconomics· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caregiver preference for rivastigmine patches versus capsules for the treatment of Alzheimer disease.
Rafael Blesa, Clive Ballard, Jean-Marc Orgogozo, Roger Lane, Simu K Thomas

Neurology· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertension.
Thomas E Delea, Charu Taneja, Aaron Moynahan, Simu K Thomas, Feride Frech-Tamas

Am J Health Syst Pharm· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer.
Thomas E Delea, Jon Karnon, Oleg Sofrygin, Simu K Thomas, Natalie L Papo

Clin Breast Cancer· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's disease.
Bengt Winblad, Ariane K Kawata, Kathleen M Beusterien, Simu K Thomas, Anders Wimo

Int J Geriatr Psychiatry· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of cancer treatment-associated bone loss and fractures among women with breast cancer receiving aromatase inhibitors.
Betty A Mincey, Mei Sheng Duh, Simu K Thomas, Erick Moyneur, Maryna Marynchencko

Clin Breast Cancer· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating costs of care for patients with newly diagnosed metastatic colorectal cancer.
L Clark Paramore, Simu K Thomas, Kevin B Knopf, Lael S Cragin, Kathy H Fraeman

Clin Colorectal Cancer· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal adverse events in a general population sample of nursing home residents taking cholinesterase inhibitors.
Anthony Hughes, Jonathan Musher, Simu K Thomas, Kathleen M Beusterien, Bill Strunk

Consult Pharm· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of knowledge, anxiety, and fear with adherence to follow up for colposcopy.
Sandra E Brooks, Nancy J Gordon, Sarah J Keller, Simu K Thomas, T Timothy Chen

J Low Genit Tract Dis· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis